Evaluation and Medical Management of Benign Prostatic Hyperplasia

Beckman, Thomas J.; Mynderse, Lance A.
October 2005
Mayo Clinic Proceedings;Oct2005, Vol. 80 Issue 10, p1356
Academic Journal
Benign prostatic hyperplasia (BPH) is common among aging men. Untreated BPH may lead to complications including urinary tract infection, acute urinary retention, and obstructive nephropathy. Diagnosing BPH can be challenging because lower urinary tract symptoms are found in conditions other than BPH, and prostate size correlates poorly with symptoms of obstruction. Nonetheless, a careful medical history and physical examination, along with prudent use of diagnostic tests, can yield an accurate diagnosis. We review the evaluation of men with suspected BPH and indications for referral to a urologist for invasive therapy. We also review supporting evidence and treatment considerations for saw palmetto and the 2 major classes of prescription medications, α1-adrenergic antagonists and 5α-reductase inhibitors.


Related Articles

  • An evidence-based review of NX1207 and its potential in the treatment of benign prostatic hyperplasia. Kunit, Thomas; Lusuardi, Lukas // Research & Reports in Urology;2014, Vol. 6, p67 

    In elderly men, benign prostatic hyperplasia is often associated with lower urinary tract symptoms, and its prevalence rises with age. Lower urinary tract symptoms can be very bothersome and lead to a decrease in health-related quality of life. Furthermore, benign prostatic hyperplasia is a...

  • Efficacy of Low-Dose Tamsulosin on Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia. Choal Hee Park, Alessandro; Hyuk Soo Chang, Alessandro; Bong Ryul Oh, Alessandro; Hyung Jee Kim, Alessandro; Chang Koo Sul, Alessandro; Sung Kwang Chung, Alessandro; Se Il Jung, Alessandro // Clinical Drug Investigation;2004, Vol. 24 Issue 1, p41 

    Objective: To evaluate the efficacy and tolerability of tamsulosin 0.2mg once daily in Korean patients with lower urinary tract symptoms (LUTS) suggestive of benign pro-static hyperplasia (BPH), who were treated for up to I year. Materials and methods: Of the 211 patients from six urology...

  • BPH/LUTS. Lee, Richard K. // AUANews;Aug2015, Vol. 20 Issue 8, p10 

    The article presents highlights of the presentations made at the 2015 American Urological Association (AUA) Annual Meeting concerning the topic of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Topics discussed include an investigation on the relationship between...

  • Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis. Xiao-yan Wang; Huan-tao Zong; Yong Zhang // Clinical Interventions in Aging;Nov2016, Vol. 11, p1609 

    Background: Prostate artery embolization (PAE) is emerging and is a promising minimally invasive therapy that improves lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH). The purpose of this article was to evaluate the efficacy and safety of PAE on LUTS related to...

  • What's best for your patient with BPH?  // Journal of Family Practice;May2009, Vol. 58 Issue 5, p241 

    The article offers information on how to manage patients with benign prostatic hyperplasia (BPH) in the U.S. It recommends the use of a urinary symptom scoring system, such as the 7-question Symptom Index for BPH and the International Prostate Symptom Score, to determine the severity of BPH and...

  • Therapeutic choices for BPH/LUTS expand, evolve. Bankhead, Charles // Urology Times;May2010, Vol. 38 Issue 6, p6 

    The article focuses on the expansion and evaluation on the therapeutic use for benign prostatic hyperplasia (BPH) /lower urinary tract infection (LUTS) to be discussed at the American Urological Association (AUA) in San Francisco, California. Steven A. Kaplan, a professor of urology and chief of...

  • Eli Lilly: Cialis's prospects boosted by positive BPH data.  // PharmaWatch: Monthly Review;Jun2009, Vol. 8 Issue 6, p20 

    In this article the author discusses the result of the clinical trial which evaluates the effectiveness of Cialis (Tadalafil) from Eli Lilly & Co. It notes that Tadafil may be effective in treating lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) in men. However,...

  • Urologic Diseases for the Allied Health Professional. Seftel, Allen; Albaugh, Jeffrey; Bodner, Donald; Kerr, Lindsey // AUANews;Nov2012 Annual Meeting Highlights, p5 

    The article discusses the guideline set by the American Urological Association (AUA) regarding the management of benign prostatic hyperplasia (BPH). It describes the AUA symptom score (AUASS) or the International Prostate Symptom Score, which is important in the evaluation of individuals...

  • A review of medicines used to treat benign prostatic hyperplasia. Coetzer, Ronelle // South African Pharmaceutical Journal;2013, Vol. 80 Issue 4, p23 

    Benign prostatic hyperplasia (BPH) is a common condition that affects ageing men and is often associated with bothersome lower urinary tract symptoms which can affect quality of life. This review will discuss the condition, as well as potential treatment options and products, which should be...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics